×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

CANDRIAM S.C.A.

AUM: $127.33 B
13-F Portfolio Value: $16.50 B
Last 13-F Filed: Q2 2024
Concentration in top 10: 18.54%
Filter by:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
PTCTPTC THERAPEUTICS INC-167,048Exited13F
PANWPALO ALTO NETWORKS INC (PRN)-175Exited13F
PENPENUMBRA INC-16,171Exited13F
PHRPHREESIA INC-177,939Exited13F
PGNYPROGYNY INC-94,056Exited13F
RAPTRAPT THERAPEUTICS INC-313,262Exited13F
RCKTROCKET PHARMACEUTICALS INC-165,000Exited13F
SKMSK TELECOM LTD-30,000Exited13F
SAGESAGE THERAPEUTICS INC-222,000Exited13F
SDGRSCHRODINGER INC-177,000Exited13F
TMCITREACE MED CONCEPTS INC-454,945Exited13F
UUNITY SOFTWARE INC-125,638Exited13F
VERVVERVE THERAPEUTICS INC-310,000Exited13F